Span Divergent Ltd-$

Span Divergent Limited has announced the closure of its trading window for promoters, directors, designated persons, and their relatives. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the company's standalone and consolidated financial results for the quarter ended June 30, 2026. During this period, no insider trading or dealing in the company's securities is permitted. The date for the board meeting to approve these financial results will be communicated separately.

Span Divergent Limited re-appointed M/s. Christie & Co., Chartered Accountants, as its Internal Auditor for the financial year 2025-26, as approved in the Board of Directors meeting held on May 30, 2026. This re-appointment complies with Section 138 of the Companies Act, 2013 and related rules. M/s. Christie & Co. has been providing audit, tax, and consulting services since 1983 and is not related to any of the company's directors.

Span Divergent Limited reported audited standalone and consolidated financial results for the year ended March 31, 2026. The Board of Directors approved these results on May 30, 2026. M/s. Y B Desai & Associates issued an unmodified opinion on the integrated audited financial results. Total income for the year ended March 31, 2026, stood at ₹222.42 lakhs. Profit after tax is ₹72.64 Lakhs.

Span Divergent Ltd's board approved the audited annual financial results (standalone & consolidated) for the year ended March 31, 2026. No dividend was recommended to conserve resources. The Annual General Meeting will be held on September 28, 2026, with the register of members closed from September 22-28, 2026. M/s. Christie & Co. were appointed as Internal Auditors for FY 2026-27.

Span Divergent Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results (standalone & consolidated) for the quarter and year ended March 31, 2026. The board will also consider dividend recommendations, appointment of an internal auditor for FY 2026-27, and finalize the date, time, and venue for the 46th Annual General Meeting. The trading window will be closed until 48 hours after the declaration of the financial results, reopening on June 02, 2026.

Span Divergent Limited announced that its subsidiary LLP, formerly known as Aranya Agri Biotech LLP, has changed its name to Aranya Consulting and Biotech LLP, effective May 19, 2026. The name change was approved by the Ministry of Corporate Affairs (MCA). This information was received from the subsidiary LLP and is disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Span Divergent Limited received trading approval from BSE Limited for 18,01,481 equity shares allotted on a preferential basis to Mr. Neev Nirav Jogani, a Non-promoter. The shares, with distinctive numbers from 7276001 to 9077481, are to be issued at a premium of ₹22.16 each. Effective from May 14, 2026, these securities are listed on the Exchange, as per Notice No. 20260513-18 dated May 13, 2026.

Span Divergent Limited received listing approval from BSE for 18,01,481 equity shares with a face value of ₹10 each, issued at ₹32.16 per share. These shares were allotted on a preferential basis to Mr. Neev Nirav Jogani, a Non-promoter, on March 28, 2026. The company has complied with Regulation 167 of SEBI (ICDR) Regulations and will file shareholding patterns in XBRL mode as required. Trading approval is contingent upon submitting NSE listing approval (if applicable) and confirmation letters from NSDL/CDSL.

Neev Nirav Jogani has acquired a 24.80% stake in Span Divergent Ltd. through a preferential allotment of shares on 28th March, 2026. This acquisition is in accordance with Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Neev Nirav Jogani has acquired a 24.80% stake in Span Divergent Ltd. through a preferential allotment on 28th March, 2026. This acquisition was made in accordance with Regulation 29(1) and Regulation 29(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The shares were acquired at a price of 0 per share. This acquisition increases Jogani's holding from 0 to 24.80% in the company.